SAAF Program for Adolescent Well-Being
(HARP-F Trial)
Trial Summary
What is the purpose of this trial?
The Health and Resilience Project (HARP): Foundations is investigating the efficacy of the Strong African American Families (SAAF) intervention in promoting the health and well being of African American adolescents. Youth age 10-13 and their primary caregivers are randomly assigned to receive SAAF or to a control group. Participants complete baseline and follow-up measures regarding vulnerability to substance use based on a neuroimmune model of stress coping.
Will I have to stop taking my current medications?
The trial does not specify if participants must stop taking their current medications, but youth with chronic illnesses or medication regimens affecting inflammatory panels are excluded.
What data supports the effectiveness of the SAAF Program for Adolescent Well-Being treatment?
Research shows that the Strong African American Families (SAAF) program effectively reduces alcohol use and deters substance use, conduct problems, and depressive symptoms in African American adolescents. The program's long-term benefits include lower rates of alcohol use and improved family relationships, which contribute to better adolescent well-being.12345
Is the SAAF program safe for participants?
The SAAF program, including its variations like SAAF-T and ProSAAF, has been studied in several trials and no safety concerns have been reported. These programs focus on family and couple-centered interventions and have shown benefits in areas like reducing substance use and improving mental health without any noted adverse effects.13456
How is the SAAF treatment different from other treatments for adolescent well-being?
The SAAF program is unique because it is a family-centered intervention specifically designed for African American adolescents, focusing on improving family communication and parenting skills to prevent high-risk behaviors, substance use, and depressive symptoms. Unlike other treatments, it includes a specific component for teaching condom skills and is delivered in community settings over seven sessions.13457
Research Team
Gene H Brody, Ph.D.
Principal Investigator
University of Georgia
Eligibility Criteria
This trial is for African American adolescents aged 10-13 and their primary caregivers. Caregivers must be the youth's primary guardian and live in the same household. Those with severe disabilities, psychoses, or conditions affecting participation are excluded, as are youths with MRI contraindications or chronic illnesses impacting inflammatory panels.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pretest Assessment
Eligible participants undergo assessments including MRI scans, blood draws, and self-report measures
Intervention
Participants receive the SAAF intervention consisting of 7 weekly online sessions
Control
Control group receives written information by mail regarding adolescent development
Follow-up
Participants are monitored for changes in NIN-associated risk markers and other outcomes
Treatment Details
Interventions
- Receipt of Parenting Book
- SAAF
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Georgia
Lead Sponsor